Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

REPL Replimune Group Inc.

盘前交易 04-19 09:10:56 EDT

6.97

-0.24

-3.33%

最高7.43	最低6.95	成交量112.62万
今开7.20	昨收7.21	日振幅6.66%
总市值4.28亿	流通市值2.72亿	总股本6,139万
成交额804.17万	换手率2.88%	流通股本3,905万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"REPL","market":"US","secType":"STK","nameCN":"Replimune Group Inc.","latestPrice":6.97,"timestamp":1713470400000,"preClose":7.21,"halted":0,"volume":1126204,"delay":0,"floatShares":39049900,"shares":61387786,"eps":-3.162073,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.24,"latestTime":"04-19 09:10:56 EDT","open":7.2,"high":7.43,"low":6.95,"amount":8041650.089266,"amplitude":0.066574,"askPrice":8.49,"askSize":1000,"bidPrice":4.95,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.162073,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713533400000},"adr":0,"listingDate":1532059200000,"adjPreClose":6.97,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":6.97,"preClose":6.97,"latestTime":"19:13 EDT","volume":24206,"amount":168724.32,"timestamp":1713481992069},"volumeRatio":1.366215057910501},"requestUrl":"/m/hq/s/REPL?invite=TIGER026","defaultTab":"news","newsList":[{"id":"2426630293","title":"Replimune Group, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426630293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426630293?lang=zh_cn&edition=full","pubTime":"2024-04-12 01:20","pubTimestamp":1712856039,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日01时20分，Replimune Group, Inc.股票出现异动，股价快速上涨5.03%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Adial Pharmaceuticals, Inc、Aptevo Therapeutics Inc.、Scisparc Ltd.较为活跃，换手率分别为764.26%、568.26%、509.21%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为50.92%、46.31%、42.60%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412012040791ff5cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412012040791ff5cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426494091","title":"Replimune Group, Inc.盘中异动 早盘大幅下挫5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426494091","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426494091?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755859,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Replimune Group, Inc.股票出现异动，股价急速下挫5.91%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为823.94%、61.97%、20.62%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、X4制药、Foghorn Therapeutics Inc.，振幅分别为19.47%、13.39%、9.52%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213059861e4a35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240410213059861e4a35&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425591870","title":"Replimune Group, Inc.盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425591870","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425591870?lang=zh_cn&edition=full","pubTime":"2024-04-06 01:20","pubTimestamp":1712337638,"startTime":"0","endTime":"0","summary":"北京时间2024年04月06日01时20分，Replimune Group, Inc.股票出现异动，股价快速上涨5.04%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为229.02%、69.92%、51.94%，振幅较大的相关个股有Candel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为90.94%、58.90%、45.85%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040601203887e7e317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040601203887e7e317&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424039757","title":"Replimune Group, Inc.盘中异动 早盘快速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424039757","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424039757?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:51","pubTimestamp":1712238713,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时51分，Replimune Group, Inc.股票出现异动，股价急速上涨5.10%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc.涨幅较大，Tc Biopharm  Plc、Candel Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃，换手率分别为1917.88%、33.43%、22.94%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为90.00%、70.00%、42.86%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215154861e368f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215154861e368f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424202905","title":"Replimune Group, Inc.盘中异动 股价大跌5.05%报7.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424202905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424202905?lang=zh_cn&edition=full","pubTime":"2024-04-03 00:13","pubTimestamp":1712074382,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日00时13分，Replimune Group, Inc.股票出现波动，股价大幅下挫5.05%。截至发稿，该股报7.34美元/股，成交量18.135万股，换手率0.30%，振幅4.01%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为1.67%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Aditxt, Inc.、Gamida Cell Ltd.涨幅较大，Aditxt, Inc.、Gamida Cell Ltd.、Avalo Therapeutics, Inc.较为活跃，换手率分别为870.10%、51.52%、36.01%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Gamida Cell Ltd.、Aditxt, Inc.，振幅分别为104.31%、61.39%、58.18%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040300130287e7dad6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040300130287e7dad6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422459969","title":"Replimune Group, Inc.盘中异动 快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422459969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422459969?lang=zh_cn&edition=full","pubTime":"2024-03-28 00:58","pubTimestamp":1711558708,"startTime":"0","endTime":"0","summary":"北京时间2024年03月28日00时58分，Replimune Group, Inc.股票出现异动，股价急速拉升5.07%。Replimune Group, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Ibio, Inc.、Moolec Science Sa C/Wts 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Ibio, Inc.、Lixte Biotechnology Holdings, Inc.、Gamida Cell Ltd.较为活跃，换手率分别为3331.75%、1229.77%、77.86%，振幅较大的相关个股有Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.，振幅分别为86.96%、78.00%、59.87%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280058297a4f8e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280058297a4f8e5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422961269","title":"Replimune Group, Inc.盘中异动 早盘股价大跌5.09%报7.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422961269","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422961269?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:31","pubTimestamp":1711463485,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日22时31分，Replimune Group, Inc.股票出现异动，股价急速下跌5.09%。截至发稿，该股报7.64美元/股，成交量8.1655万股，换手率0.13%，振幅7.20%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Nutriband Inc C/Wts 、Artelo Biosciences Inc C/Wts 20/06/2024 、Stoke Therapeutics, Inc.涨幅较大，Abvc Biopharma, Inc.、Altamira Therapeutics Ltd.、Stoke Therapeutics, Inc.较为活跃，换手率分别为204.87%、28.36%、27.83%，振幅较大的相关个股有Nutriband Inc C/Wts 、Stoke Therapeutics, Inc.、Mesoblast Ltd，振幅分别为109.68%、34.92%、32.27%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032622312587e7bdfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032622312587e7bdfa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421321046","title":"Replimune Group, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421321046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421321046?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:44","pubTimestamp":1711028687,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时44分，Replimune Group, Inc.股票出现异动，股价快速上涨5.12%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Xtl生物制药较为活跃，换手率分别为71.75%、15.00%、14.86%，振幅较大的相关个股有Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Briacell Therapeutics Corp C/Wts，振幅分别为44.42%、22.90%、19.40%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212144477a4e4131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212144477a4e4131&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416142477","title":"Replimune Group, Inc.盘中异动 股价大跌5.02%报8.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416142477","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416142477?lang=zh_cn&edition=full","pubTime":"2024-03-04 22:31","pubTimestamp":1709562717,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日22时31分，Replimune Group, Inc.股票出现异动，股价快速下挫5.02%。截至发稿，该股报8.52美元/股，成交量8584股，换手率0.01%，振幅1.78%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Quoin Pharmaceuticals Ltd、Jaguar Health, Inc.、Gri Bio, Inc.较为活跃，换手率分别为990.99%、131.55%、43.93%，振幅较大的相关个股有Absci Corporation、Sonnet Biotherapeutics Holdings, Inc.、Synlogic, Inc.，振幅分别为112.64%、104.42%、100.00%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030422315787e75aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030422315787e75aaa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416286026","title":"Replimune Group, Inc.盘中异动 急速拉升5.07%报9.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416286026","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416286026?lang=zh_cn&edition=full","pubTime":"2024-03-01 23:56","pubTimestamp":1709308563,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日23时56分，Replimune Group, Inc.股票出现异动，股价大幅拉升5.07%。截至发稿，该股报9.02美元/股，成交量13.3596万股，换手率0.22%，振幅4.14%。Replimune Group, Inc.股票所在的生物技术行业中，整体涨幅为2.45%。其相关个股中，Biovie Inc.、Adial Pharmaceuticals, Inc、Jaguar Health, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Enveric Biosciences, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3568.48%、381.41%、287.47%，振幅较大的相关个股有Biovie Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Jaguar Health, Inc.，振幅分别为83.06%、81.48%、81.19%。Replimune Group, Inc.公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012356047a4899bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012356047a4899bd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414701835","title":"Replimune Group Inc盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414701835","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414701835?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:47","pubTimestamp":1708958844,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时47分，Replimune Group Inc股票出现波动，股价快速拉升5.10%。Replimune Group Inc股票所在的生物技术行业中，整体涨幅为0.29%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。该公司使用专有的RPx平台来设计和开发候选产品，旨在最大限度地激活免疫系统，对抗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022622472587e7327e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022622472587e7327e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413223316","title":"Replimune Group Inc盘中异动 股价大涨5.04%报8.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413223316","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413223316?lang=zh_cn&edition=full","pubTime":"2024-02-23 03:07","pubTimestamp":1708628867,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日03时07分，Replimune Group Inc股票出现异动，股价快速上涨5.04%。截至发稿，该股报8.03美元/股，成交量27.4443万股，换手率0.45%，振幅7.46%。Replimune Group Inc股票所在的生物技术行业中，整体涨幅为2.25%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。该公司使用专有的RPx平台来设计和开发候选产品，旨在最大限度地激活免疫系统，对抗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402230307477a45c63b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402230307477a45c63b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411412375","title":"Replimune Group Inc盘中异动 早盘股价大涨5.24%报7.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411412375","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411412375?lang=zh_cn&edition=full","pubTime":"2024-02-15 22:33","pubTimestamp":1708007627,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日22时33分，Replimune Group Inc股票出现异动，股价快速上涨5.24%。截至发稿，该股报7.23美元/股，成交量2.1995万股，换手率0.04%，振幅2.33%。Replimune Group Inc股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Coeptis Therapeutics Holdings Inc、Orgenesis Inc、Clene Inc C/Wts 30/12/2025 涨幅较大，Kintara Therapeutics Inc、Adial Pharmaceuticals Inc、Jaguar Health Inc较为活跃，换手率分别为25.43%、16.68%、11.72%，振幅较大的相关个股有Sol Gel Technologies Ltd、Coeptis Therapeutics Holdings Inc、Adaptive Biotechnologies Corp，振幅分别为16.67%、14.42%、13.96%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522334887e70310&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021522334887e70310&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411539243","title":"Replimune Group Inc盘中异动 快速下跌5.10%报6.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411539243","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411539243?lang=zh_cn&edition=full","pubTime":"2024-02-15 04:52","pubTimestamp":1707943971,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日04时52分，Replimune Group Inc股票出现波动，股价快速跳水5.10%。Replimune Group Inc股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Engene Holdings Inc C/Wts 31/10/2028  Cl A、Engene Holdings Inc、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Adial Pharmaceuticals Inc、Kintara Therapeutics Inc、Panbela Therapeutics Inc较为活跃，换手率分别为426.54%、116.18%、104.85%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Telomir Pharmaceuticals Inc、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为224.76%、195.38%、161.60%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215045251861d548b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240215045251861d548b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411350227","title":"Replimune Group Inc盘中异动 早盘急速下挫5.66%报7.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411350227","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411350227?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834704,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分，Replimune Group Inc股票出现波动，股价大幅跳水5.66%。截至发稿，该股报7.50美元/股，成交量7838股，换手率0.01%，振幅1.26%。Replimune Group Inc股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为296.07%、81.36%、29.63%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Biovie Inc、Rhythm Pharmaceuticals Inc，振幅分别为12.41%、12.28%、10.90%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322314479113bab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322314479113bab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2410056912","title":"Replimune Group Inc盘中异动 早盘大幅上涨5.83%报8.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2410056912","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2410056912?lang=zh_cn&edition=full","pubTime":"2024-02-09 22:33","pubTimestamp":1707489183,"startTime":"0","endTime":"0","summary":"北京时间2024年02月09日22时33分，Replimune Group Inc股票出现波动，股价快速上涨5.83%。截至发稿，该股报8.17美元/股，成交量3.7227万股，换手率0.06%，振幅2.46%。Replimune Group Inc股票所在的生物技术行业中，整体涨幅为0.49%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。该公司使用专有的RPx平台来设计和开发候选产品，旨在最大限度地激活免疫系统，对抗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020922330387815a89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020922330387815a89&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409108827","title":"Replimune 集团公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2409108827","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409108827?lang=zh_cn&edition=full","pubTime":"2024-02-08 22:30","pubTimestamp":1707402612,"startTime":"0","endTime":"0","summary":"   * Replimune Group Inc   报告，截至12月底的季度调整后每股亏损77美分，低于去年同期的每股收益-69美分。九位分析师对该季度的平均预期是每股亏损 93 美分。华尔街预期为每股亏损-1.01 美元至-85 美分。* Replimune Group Inc报告的季度每股收益为亏损77美分。* 该公司当季亏损 5112 万美元。* Replimune Group Inc 本季度股价下跌了 12.0%。* 华尔街对 Replimune Group Inc 的 12 个月目标价中位数为 13.00 美元。本摘要由 LSEG 2 月 8 日 02:29 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2409400354","title":"Replimune Group Inc盘中异动 大幅拉升5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2409400354","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409400354?lang=zh_cn&edition=full","pubTime":"2024-02-06 23:39","pubTimestamp":1707233966,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日23时39分，Replimune Group Inc股票出现异动，股价急速上涨5.25%。Replimune Group Inc股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Revelation Biosciences Inc较为活跃，换手率分别为2419.17%、2020.99%、97.58%，振幅较大的相关个股有Invivo Therapeutics Holding Corp、Tenax Therapeutics Inc、Karyopharm Therapeutics Inc，振幅分别为143.74%、83.26%、61.48%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240206233927790faf18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240206233927790faf18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409436128","title":"Replimune Group Inc    预计每股亏损 93 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2409436128","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2409436128?lang=zh_cn&edition=full","pubTime":"2024-02-05 23:25","pubTimestamp":1707146713,"startTime":"0","endTime":"0","summary":"   * Replimune Group Inc    将于2月7日公布截至2023年12月31日的财报    *    * LSEG 的分析师平均预计 Replimune Group Inc 每股亏损 93 美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，建议分类为 10 个 \"强烈买入 \"或 \"买入\"，没有 \"持有\"，也没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Replimune Group Inc 的 12 个月目标价中位数为 13.00 美元，高于其最新收盘价 7.34 美元。2月5日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2408982020","title":"Replimune Group Inc盘中异动 早盘股价大跌5.15%报7.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408982020","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408982020?lang=zh_cn&edition=full","pubTime":"2024-02-02 22:49","pubTimestamp":1706885383,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日22时49分，Replimune Group Inc股票出现波动，股价急速下跌5.15%。截至发稿，该股报7.46美元/股，成交量6.3674万股，换手率0.11%，振幅4.64%。Replimune Group Inc股票所在的生物技术行业中，整体跌幅为1.16%。Replimune Group Inc公司简介：Replimune Group Inc是一家临床阶段生物技术公司。该公司使用专有的RPx平台来设计和开发候选产品，旨在最大限度地激活免疫系统，对抗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020222494487e6c317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020222494487e6c317&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.replimune.com","stockEarnings":[{"period":"1week","weight":-0.0306},{"period":"1month","weight":-0.1562},{"period":"3month","weight":-0.0731},{"period":"6month","weight":-0.5303},{"period":"1year","weight":-0.5866},{"period":"ytd","weight":-0.1732}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0314},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.186},{"period":"1year","weight":0.2062},{"period":"ytd","weight":0.0509}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Replimune Group, Inc.于2015年在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于应用他们在溶瘤免疫治疗领域的领先专业技术，改变癌症患者的生活。使用该公司专有的Immulytic平台来设计和开发旨在最大限度激活免疫系统对抗癌症的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002034},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.066883},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.078936},{"month":4,"riseRate":0.5,"avgChangeRate":0.150609},{"month":5,"riseRate":0.6,"avgChangeRate":-0.017819},{"month":6,"riseRate":0.8,"avgChangeRate":0.16384},{"month":7,"riseRate":0.2,"avgChangeRate":-0.097379},{"month":8,"riseRate":0.333333,"avgChangeRate":0.067123},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.049404},{"month":10,"riseRate":0.5,"avgChangeRate":0.124924},{"month":11,"riseRate":0.5,"avgChangeRate":0.010871},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.088051}],"exchange":"NASDAQ","name":"Replimune Group Inc.","nameEN":"Replimune Group Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Replimune Group Inc.,REPL,Replimune Group Inc.股票,Replimune Group Inc.股票老虎,Replimune Group Inc.股票老虎国际,Replimune Group Inc.行情,Replimune Group Inc.股票行情,Replimune Group Inc.股价,Replimune Group Inc.股市,Replimune Group Inc.股票价格,Replimune Group Inc.股票交易,Replimune Group Inc.股票购买,Replimune Group Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Replimune Group Inc.(REPL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Replimune Group Inc.(REPL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}